Oakworth Capital’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,671
Closed -$254K 624
2018
Q3
$254K Hold
2,671
0.05% 144
2018
Q2
$206K Buy
2,671
+23
+0.9% +$1.73K 0.04% 157
2018
Q1
$201K Buy
2,648
+511
+24% +$39K 0.05% 154
2017
Q4
$140K Sell
2,137
-325
-13% -$20.8K 0.03% 184
2017
Q3
$155K Buy
2,462
+100
+4% +$6.21K 0.04% 180
2017
Q2
$151K Hold
2,362
0.04% 181
2017
Q1
$155K Buy
2,362
+155
+7% +$10.7K 0.04% 173
2016
Q4
$167K Buy
2,207
+405
+22% +$29K 0.05% 166
2016
Q3
$127K Buy
1,802
+10
+0.6% +$748 0.04% 181
2016
Q2
$136K Buy
1,792
+1,624
+967% +$119K 0.05% 177
2016
Q1
$12K Hold
168
﹤0.01% 360
2015
Q4
$15K Hold
168
0.01% 323
2015
Q3
$14K Hold
168
0.01% 277
2015
Q2
$15K Hold
168
0.01% 282
2015
Q1
$15K Sell
168
-127
-43% -$10.7K 0.01% 296
2014
Q4
$25K Buy
295
+16
+6% +$1.25K 0.01% 245
2014
Q3
$21K Hold
279
0.01% 227
2014
Q2
$19K Hold
279
0.01% 239
2014
Q1
$21K Hold
279
0.01% 226
2013
Q4
$20K Buy
+279
New +$18.2K 0.01% 209

Other funds holding ESRX

Oakworth Capital's ESRX Position: Q4 2018 in Review

Oakworth Capital sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 2,671 shares — an estimated $254K sold.

Oakworth Capital first reported a position in ESRX in Q4 2013 and held it in 20 quarters. The position peaked at $254K in Q3 2018. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Oakworth Capital reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Oakworth Capital sold 2,671 Express Scripts Holding Company shares in Q4 2018, an estimated $254K.
  • Oakworth Capital first reported a position in Express Scripts Holding Company in Q4 2013 and held it in 20 quarters.
  • Oakworth Capital's Express Scripts Holding Company position peaked at $254K in Q3 2018.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Oakworth Capital's 13F filing for Q4 2018, filed 13 Feb 2019.